Usage of Phenytoin in Treatment of severe Headache in COVID-19 Patients
Subject Areas :
Journal of Chemical Health Risks
Hayder Alhemiary
1
,
Dhuha Almayoof
2
1 - M.B.Ch.B., F.I.C.M.S (Neurosurgery), Instructor, Baghdad Medical College, Consultant Neuro & Orbital Surgery, Medical City, Department of Neurosurgery, Iraq
2 - M.B.Ch.B., CABS, Specialized Radiology, Medical City, Alshahid Ghzi, Department of Radiology, Iraq
Received: 2021-10-10
Accepted : 2022-03-05
Published : 2022-12-01
Keywords:
References:
Zhou M., Zhang X., Qu J., 2020. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 14(2), 126-135.
Belvis R., 2020. Headaches during COVID-19: My Clinical Case and Review of the Literature. Headache. 60(7), 1422-1426.
COVID-19 and headaches: What you need to know Headache is often an early warning By Cliff Mehrtens.https://www.novanthealth.org/healthy-headlines/covid-19-and-headaches-what-you-need-to-know, November, 2, 2020.
COVID-19 and Headaches, By Dr. Osman Shabir, PhD https://www.news-medical.net/health/COVID-19-and-Headache.aspx.
Caronna E., Ballvé A., Llauradó A., Gallardo V.J., Ariton D.M., Lallana S., Lopez Maza S., Olive Gadea M., Quibus L., Restrepo J.L., Rodrigo-Gisbert M., 2020. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 40(13), 1410-1421.
Pain Scale Chart: 1 to 10 Levels: Published: 2016-05-20 -Updated: 2020-03-12:https://www.disabled-world. com/ health/pain/scale.php.
MaassenVan Den Brink A., de Vries T., Danser A.H.J., 2020. Headache medication and the COVID-19 pandemic. J Headache Pain. 21(1), 38.
World Health Organization. https://www. who.int/ healthtopics /coronavirus#tab=tab_3 (2020, accessed 10 August 2020).
Hesselink J.M., Schatman M.E., 2017. Phenytoin and carbamazepine in trigeminal neuralgia: marketing-based versus evidence-based treatment. Journal of Pain Research. 10, 1663.
Arca K.N., Smith J.H., Chiang C.C., Starling A.J., Robertson C.E., Halker Singh R.B., Schwedt T.J., Kissoon N.R., Garza I., Rozen T.D., Boes C.J, 2020. COVID‐19 and headache medicine: a narrative review of non‐steroidal anti‐inflammatory drug (NSAID) and corticosteroid use. Headache: The Journal of Head and Face Pain. 60(8), 1558-68.
Arca K.N., Starling A.J., 2020. Treatment-refractory headache in the setting of COVID-19 pneumonia: migraine or meningoencephalitis? Case report. SN Comprehensive Clinical Medicine. 2(8), 1200-3.
Morollón N., Belvís R., De Dios A., Pagès N., González-Oria C., Latorre G., Santos-Lasaosa S., 2020. Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology’s Headache Study Group. Neurología (English Edition). 35(9), 628-32.
MaassenVan Den Brink A., De Vries T., Danser A.J., 2020. Headache medication and the COVID-19 pandemic. The Journal of Headache and Pain. 21(1), 1-4.